These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 9018235)

  • 21. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
    Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells.
    Everitt EA; Sage EH
    Exp Cell Res; 1992 Mar; 199(1):134-46. PubMed ID: 1310471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
    Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
    Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth.
    Lopez MV; Blanco P; Viale DL; Cafferata EG; Carbone C; Gould D; Chernajovsky Y; Podhajcer OL
    Mol Cancer Ther; 2006 Oct; 5(10):2503-11. PubMed ID: 17041094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
    Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
    Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of SPARC gene in tumorigenic capacity of human melanoma cells].
    Ledda MF; Adris S; Bover L; Bravo AL; Mordoh J; Podhajcer OL
    Medicina (B Aires); 1996; 56(1):51-4. PubMed ID: 8734932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition.
    Dhanesuan N; Sharp JA; Blick T; Price JT; Thompson EW
    Breast Cancer Res Treat; 2002 Sep; 75(1):73-85. PubMed ID: 12500936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells.
    Sosa MS; Girotti MR; Salvatierra E; Prada F; de Olmo JA; Gallango SJ; Albar JP; Podhajcer OL; Llera AS
    Proteomics; 2007 Nov; 7(22):4123-34. PubMed ID: 17994631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPARC/osteonectin is involved in metastatic process to the lung during melanoma progression.
    Botti G; Scognamiglio G; Marra L; Collina F; Di Bonito M; Cerrone M; Grilli B; Anniciello A; Franco R; Fulciniti F; Ascierto PA; Cantile M
    Virchows Arch; 2014 Sep; 465(3):331-8. PubMed ID: 24993904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
    Miele ME; Bennett CF; Miller BE; Welch DR
    Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.
    Girotti MR; Fernández M; López JA; Camafeita E; Fernández EA; Albar JP; Benedetti LG; Valacco MP; Brekken RA; Podhajcer OL; Llera AS
    J Invest Dermatol; 2011 Dec; 131(12):2438-47. PubMed ID: 21850018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
    Sun W; Feng J; Yi Q; Xu X; Chen Y; Tang L
    Biofactors; 2018 Sep; 44(5):453-464. PubMed ID: 30346081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolipid protein 2 is associated with melanoma metastasis.
    Sonoda Y; Warita M; Suzuki T; Ozawa H; Fukuda Y; Funakoshi-Tago M; Kasahara T
    Oncol Rep; 2010 Feb; 23(2):371-6. PubMed ID: 20043097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity.
    Alvarez MJ; Prada F; Salvatierra E; Bravo AI; Lutzky VP; Carbone C; Pitossi FJ; Chuluyan HE; Podhajcer OL
    Cancer Res; 2005 Jun; 65(12):5123-32. PubMed ID: 15958556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
    Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPARC was overexpressed in human endometrial cancer stem-like cells and promoted migration activity.
    Yusuf N; Inagaki T; Kusunoki S; Okabe H; Yamada I; Matsumoto A; Terao Y; Takeda S; Kato K
    Gynecol Oncol; 2014 Aug; 134(2):356-63. PubMed ID: 24769035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
    Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
    J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.
    Mok SC; Chan WY; Wong KK; Muto MG; Berkowitz RS
    Oncogene; 1996 May; 12(9):1895-901. PubMed ID: 8649850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
    Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
    Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.